Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
								
																		
									
																											
																		
									
																											
																		
									
										
											Monoisotopic mass 
										
										
											453.068019442										
									 
																											
									
																		
									
										
											InChI 
										
										
											InChI=1S/C21H18F3NO3S2/c1-12-9-16(7-8-17(12)28-10-19(26)27)29-11-18-13(2)25-20(30-18)14-3-5-15(6-4-14)21(22,23)24/h3-9H,10-11H2,1-2H3,(H,26,27)										
									 
																		
																		
										
											InChI Key 
										
										
											InChIKey=YDBLKRPLXZNVNB-UHFFFAOYSA-N										
									 
																											
																		
										
											IUPAC Name 
										
										
											2-{2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxy}acetic acid										
									 
																											
																		
										
											Traditional IUPAC Name 
										
										
											2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxyacetic acid										
									 
																											
									
																		
										
											SMILES 
										
										
											CC1=C(CSC2=CC(C)=C(OCC(O)=O)C=C2)SC(=N1)C1=CC=C(C=C1)C(F)(F)F										
									 
																		
																		
									
																		
																		
																		
																											
																		
																											
																		
																											
																		
										
											pKa (strongest acidic) 
										
										
											3.51										
									 
																											
																		
										
											pKa (Strongest Basic) 
										
										
											2.14										
									 
																											
																		
																											
																		
										
											Refractivity 
										
										
											121.88 m3·mol-1
										
									 
																			  
		  
																		
																											
																		
																		
									
																		
																		
																		
																		
																		
																		
																		
											  
		  
								 
							 	
														
														
															
								 Cơ Chế Tác Dụng : 
								
									GW-501516 is a peroxisome proliferator-activator receptor-delta agonist for the potential treatment of dyslipidemia. It is developed by GlaxoSmithKline. This drug is in Phase II clinical trials .								
								
									This drug regulates  fatty acid oxidation in several tissues, such as skeletal muscle and adipose tissue. Overexpression of PPARdelta using a transgenic murine model promotes an increase of muscle oxidative capability. It also plays a major role in the metabolic adaptations to western diet characterized by an excessive amount of saturated fat.								
							
														
														
														
							
																					
								 Chỉ Định : 
								
									Investigated for use/treatment in hyperlipidemia.